Progyny (PGNY) Revenue (2018 - 2026)

Progyny (PGNY) has 9 years of Revenue data on file, last reported at $328.5 million in Q1 2026.

• Quarterly Revenue rose 1.38% year-over-year to $328.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 6.59% YoY) and the FY2025 annual result came in at $1.3 billion, up 10.4% from the prior year.
• Revenue grew to $328.5 million in Q1 2026 per PGNY's latest filing, from $318.4 million in the prior quarter.
• Across five years, Revenue topped out at $332.9 million in Q2 2025 and bottomed at $172.2 million in Q1 2022.
• The 5-year median for Revenue is $280.9 million (2023), against an average of $274.1 million.
• The widest annual swing landed in 2022, when Revenue jumped 68.03%; it then grew 1.38% in 2026.
• Tracing PGNY's Revenue over 5 years: stood at $214.3 million in 2022, then increased by 25.95% to $269.9 million in 2023, then climbed by 10.55% to $298.4 million in 2024, then advanced by 6.69% to $318.4 million in 2025, then rose by 3.17% to $328.5 million in 2026.
• Per Business Quant, the three latest PGNY Revenue figures stand at $328.5 million (Q1 2026), $318.4 million (Q4 2025), and $313.3 million (Q3 2025).

Peer Comparison